These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34869004)

  • 1. Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder.
    Li Y; Zhang K; Yang F; Jiao D; Li M; Zhao X; Xu C; Liu S; Li H; Shi S; Yang B; Yang L; Han D; Wen W; Qin W
    Front Oncol; 2021; 11():771036. PubMed ID: 34869004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma.
    Zhang K; Xu C; Liu S; Jiang Y; Zhao X; Ma S; Li Y; Yang F; Wang Y; Meng P; Shi C; Han D; Wen W; Qin W
    Front Oncol; 2021; 11():644612. PubMed ID: 33791227
    [No Abstract]   [Full Text] [Related]  

  • 3. Downregulation of miR-133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder.
    Chen X; Wu B; Xu Z; Li S; Tan S; Liu X; Wang K
    Cancer Med; 2016 Aug; 5(8):1856-62. PubMed ID: 27292588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD248 as a bridge between angiogenesis and immunosuppression: a promising prognostic and therapeutic target for renal cell carcinoma.
    Liu S; Xu C; Zhang K; Han D; Yang F; Li Y; Zhao X; Ma S; Li H; Lu S; Lu T; Zhang J; Qin W; Wen W; Yang B
    Ann Transl Med; 2021 Dec; 9(23):1741. PubMed ID: 35071435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of TRPM8 is associated with poor prognosis in urothelial carcinoma of bladder.
    Xiao N; Jiang LM; Ge B; Zhang TY; Zhao XK; Zhou X
    Tumour Biol; 2014 Nov; 35(11):11499-504. PubMed ID: 25128062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
    Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.
    Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L
    Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate specific membrane antigen (PSMA) in urothelial cell carcinoma (UCC) is associated with tumor grading and staging.
    Schreiber H; Hänze J; Nimphius W; Verburg FA; Luster M; Hofmann R; Hegele A
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):305-313. PubMed ID: 31897687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical biomarkers for bladder cancer prognosis.
    Matsushita K; Cha EK; Matsumoto K; Baba S; Chromecki TF; Fajkovic H; Sun M; Karakiewicz PI; Scherr DS; Shariat SF
    Int J Urol; 2011 Sep; 18(9):616-29. PubMed ID: 21771101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A California Cancer Registry Analysis of Urothelial and Non-urothelial Bladder Cancer Subtypes: Epidemiology, Treatment, and Survival.
    Martin JW; Jefferson FA; Huang M; Sung JM; Chang J; Piranviseh K; Ziogas A; Anton-Culver H; Youssef RF
    Clin Genitourin Cancer; 2020 Jun; 18(3):e330-e336. PubMed ID: 32144047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
    Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
    APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study.
    Nuhn P; Novara G; Seitz C; Gupta A; Matsumoto K; Kassouf W; Walton TJ; Fritsche HM; Tritschler S; Martínez-Salamanca JI; Ficarra V; Karakiewicz PI; Mazzoleni G; Shariat SF; Bastian PJ
    World J Urol; 2015 Jul; 33(7):1005-13. PubMed ID: 25048439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of TMEM67 is a critical predictor of poor prognosis in human urothelial carcinoma of the bladder.
    Du E; Zhang C; Qin Z; Yang K; Li C; Wang A; Zhang Z; Xu Y
    Urol Oncol; 2017 Apr; 35(4):152.e7-152.e12. PubMed ID: 28161324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fascin expression in urinary bladder urothelial carcinoma correlates with unfavourable prognosis.
    Gomaa W; Al-Maghrabi H; Al-Attas M; Al-Ghamdi F; Al-Maghrabi J
    Int J Clin Exp Pathol; 2019; 12(10):3901-3907. PubMed ID: 31933780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
    Mitra AP; Bartsch CC; Bartsch G; Miranda G; Skinner EC; Daneshmand S
    Urol Oncol; 2014 Feb; 32(2):117-27. PubMed ID: 23477878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of long non-coding RNA HNF1A-AS1 is associated with poor prognosis in urothelial carcinoma of the bladder.
    Wang YH; Liu YH; Ji YJ; Wei Q; Gao TB
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2261-2265. PubMed ID: 29762827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitinase 3-like 1 expression associated with lymphatic metastasis and prognosis in urothelial carcinoma of the bladder.
    Wang B; Chen K; Gao M; Sun X; He W; Chen J; Yang W; Yang T; Qin H; Ruan H; Huang H; Lin T; Huang J
    Clin Transl Immunology; 2024; 13(4):e1505. PubMed ID: 38623539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.
    Yang L; Li C; Qin Y; Zhang G; Zhao B; Wang Z; Huang Y; Yang Y
    Front Oncol; 2021; 11():686044. PubMed ID: 34422642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
    Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
    Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.